- Home
- AMPH vs RXRX Comparison
AMPH vs RXRX Comparison
Compare AMPH & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPH
- RXRX
- Stock Information
- Founded
- AMPH 1996
- RXRX 2013
- Country
- AMPH United States
- RXRX United States
- Employees
- AMPH N/A
- RXRX N/A
- Industry
- AMPH Biotechnology: Pharmaceutical Preparations
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- AMPH Health Care
- RXRX Health Care
- Exchange
- AMPH Nasdaq
- RXRX Nasdaq
- Market Cap
- AMPH 2.5B
- RXRX 2.6B
- IPO Year
- AMPH 2014
- RXRX 2021
- Fundamental
- Price
- AMPH $39.54
- RXRX $6.03
- Analyst Decision
- AMPH Buy
- RXRX Buy
- Analyst Count
- AMPH 4
- RXRX 5
- Target Price
- AMPH $60.33
- RXRX $9.25
- AVG Volume (30 Days)
- AMPH 607.1K
- RXRX 16.5M
- Earning Date
- AMPH 11-06-2024
- RXRX 11-06-2024
- Dividend Yield
- AMPH N/A
- RXRX N/A
- EPS Growth
- AMPH 17.38
- RXRX N/A
- EPS
- AMPH 3.01
- RXRX N/A
- Revenue
- AMPH $723,549,000.00
- RXRX $65,184,000.00
- Revenue This Year
- AMPH $16.86
- RXRX $60.17
- Revenue Next Year
- AMPH $10.07
- RXRX $19.88
- P/E Ratio
- AMPH $13.01
- RXRX N/A
- Revenue Growth
- AMPH 20.33
- RXRX 37.64
- 52 Week Low
- AMPH $36.56
- RXRX $5.60
- 52 Week High
- AMPH $65.92
- RXRX $15.74
- Technical
- Relative Strength Index (RSI)
- AMPH 30.89
- RXRX 41.92
- Support Level
- AMPH $38.78
- RXRX $6.75
- Resistance Level
- AMPH $45.39
- RXRX $7.85
- Average True Range (ATR)
- AMPH 1.36
- RXRX 0.74
- MACD
- AMPH -0.34
- RXRX -0.15
- Stochastic Oscillator
- AMPH 15.69
- RXRX 2.49
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.